Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04032444 · ClinicalTrials.gov registry record
Collecting Orthopedic Safety and Performance Data Using Surgeons Clinical Outcomes Registry (SCOR)
A clinical trial, sponsored by Stryker Trauma and Extremities.
- Terminated
- Registry status
- 723
- Enrollment target
NCT04032444: Clinical Trial study, sponsored by Stryker Trauma and Extremities.
NCT04032444 is a clinical trial that was terminated before completion, run by Stryker Trauma and Extremities. The registered enrollment target is 723 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04032444 was terminated before completion, sponsored by Stryker Trauma and Extremities.
- TERMINATED
- Registry status
- 723 participants
- Enrollment target
Study Summary
The Surgeons Clinical Outcomes Registry (SCOR) is a global registry designed to collect safety and performance data on commercially available Wright Medical products. Registry data may be used for publications, education and marketing materials, post-market surveillance, future regulatory submissions, research and development for product design, software improvements, and development of artificial intelligence learning and tools.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 723 participants |
| Start Date | 2019-07-30 |
| Est. Completion | 2022-01-21 |
Why NCT04032444 stopped before completion
NCT04032444 is an observational study that tracks outcomes without assigning an intervention. The registered 723 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04032444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04032444 about?
NCT04032444 is a clinical study titled "Collecting Orthopedic Safety and Performance Data Using Surgeons Clinical Outcomes Registry (SCOR)". The Surgeons Clinical Outcomes Registry (SCOR) is a global registry designed to collect safety and performance data on commercially available Wright Medical products. Registry data may be used for publications, education and marketing materials, post-market surveillance, future regulatory submission...
What is the current status of trial NCT04032444?
This trial is currently terminated. The enrollment target is 723 participants. The study started on 2019-07-30. Estimated completion is 2022-01-21.
Who is sponsoring clinical trial NCT04032444?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06641466 · 723 participants · Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- NCT07088068 · 723 participants · Phase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- NCT06664619 · 724 participants · Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- NCT06116149 · 722 participants · NA
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI